(Insert Table 3 here)
Second-round survey
Most of the statements (92.0%) reached consensus in this round. Similar
to the first-round survey results, the statements’ agreement scores were
high particularly on statements related to community surveillance and
home visits for women with HDP (mean agreement scores: 98.0%). Five
statements did not reach consensus in this round and the statements were
re-tested in the third-round survey (Please refer to Table 2 and the
supplementary table).
Seven participants also revised their responses to statements in the
first-round survey and increased the agreement scores to above 70.0%
for three statements: ‘systemic lupus erythematosus as a risks
factor for preeclampsia ’ (72.9%), ‘serum creatinine as a
baseline examination for women with preeclampsia risk factors ’ (70.8%)
and ‘low dose aspirin prescription by GPs ’ (70.8%).
Some participants in the free-text questions in this round raised
further opinions regarding authority of HDP in primary care, such as
suggesting different management of mild and severe preeclampsia based on
their usual practice and a need for a government policy to facilitate
the pathways’ implementation in practice (Table 3). Again, a participant
also wrote another limitation in practice, i.e that only certain
medicine available in primary care.